Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Ramesh, Geeta ^a   Maclean, Andrew G ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BACTERIAL MENINGITIS; BRAIN ABSCESS; CELL ACTIVATION; CYTOKINE RELEASE; DEMYELINATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACELLULAR SIGNALING; LYME DISEASE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROTOXICITY; NEUTROPHIL; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS INFECTION; VIRUS ENCEPHALITIS; ANIMAL; CYTOLOGY; DEGENERATIVE DISEASE; ENCEPHALITIS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; NEURALGIA; PHAGOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ASTROCYTES; BRAIN ABSCESS; CHEMOKINES; CYTOKINES; ENCEPHALITIS; HIV INFECTIONS; HUMANS; INFLAMMATION; LYME NEUROBORRELIOSIS; MENINGITIS, BACTERIAL; MENINGITIS, PNEUMOCOCCAL; MICROGLIA; NEURALGIA; NEURODEGENERATIVE DISEASES; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84884246344     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/480739     Document Type: Article

References (252)

1. Vilcek J., Angus W., Thomson M. T. L., The cytokines: an overview. The Cytokine Handbook 4th San Diego, Calif, USA Academic Press 1 18
2. Walz A., Peveri P., Aschauer H., Baggiolini M., Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochemical and Biophysical Research Communications 1987 149 2 755 761 2-s2.0-0023554062
3. Yoshimura T., Matsushima K., Oppenheim J. J., Leonard E. J., Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). Journal of Immunology 1987 139 3 788 793 2-s2.0-0023222178
4. Moser B., Loetscher P., Lymphocyte traffic control by chemokines. Nature Immunology 2001 2 2 123 128 2-s2.0-0035257205 10.1038/84219
5. Devi L. A., G-protein-coupled receptor dimers in the lime light. Trends in Pharmacological Sciences 2000 21 9 324 326 2-s2.0-0034284013 10.1016/S0165-6147(00)01519-4
6. Hickey W. F., Leukocyte traffic in the central nervous system: the participants and their roles. Seminars in Immunology 1999 11 2 125 137 2-s2.0-0032908722 10.1006/smim.1999.0168
7. Takeshita Y., Ransohoff R. M., Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunological Reviews 2012 248 228 239
8. Benveniste E. N., Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. American Journal of Physiology 1992 263 1 C1 C16 2-s2.0-0026638409
9. Cámara-Lemarroy C. R., Guzmán-de La Garza F. J., Fernández-Garza N. E., Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. NeuroImmunoModulation 2010 17 5 314 324 2-s2.0-77950939844 10.1159/000292020
10. Watkins L. R., Maier S. F., Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiological Reviews 2002 82 4 981 1011 2-s2.0-0036788082
11. Nilupul P. M., Ma H. K., Arakawa S., Howells D. W., Markus R., Rowe C. C., Donnan G. A., Inflammation following stroke. Journal of Clinical Neuroscience 2006 13 1 1 8 2-s2.0-30344479448 10.1016/j.jocn.2005.07.005
12. De Chiara G., marcocci M. E., Sgarbanti R., Infectious agents and neurodegeneration. Molecular Neurobiology 2012 10. 1007/S12035-012-8320-7
13. Vilhardt F., Microglia: phagocyte and glia cell. International Journal of Biochemistry and Cell Biology 2005 37 1 17 21 2-s2.0-4644308783 10.1016/j.biocel.2004.06.010
14. Gendelman H. E., Neural immunity: friend or foe? Journal of NeuroVirology 2002 8 6 474 479 2-s2.0-0036948724 10.1080/13550280290168631
15. Erta M., Quintana A., Hidalgo J., Interleukin-6 a major cytokine in the central nervous system. International Journal of Biological Sciences 2012 8 1254 1266
16. Ye L., Huang Y., Zhao L., IL-1 β and TNF- α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. Journal of Neurochemistry 2013 125 6 897 908
17. Kumar M., Verma S., Nerurkar V. R., Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. Journal of Neuroinflammation 2010 7, article 73 2-s2.0-77958527908 10.1186/1742-2094-7-73
18. Lazovic J., Basu A., Lin H.-W., Rothstein R. P., Krady J. K., Smith M. B., Levison S. W., Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke 2005 36 10 2226 2231 2-s2.0-26444459796 10.1161/01.STR.0000182255.08162.6a
19. Takahashi J. L., Giuliani F., Power C., Imai Y., Yong V. W., Interleukin-1 β promotes oligodendrocyte death through glutamate excitotoxicity. Annals of Neurology 2003 53 5 588 595 2-s2.0-0038416100 10.1002/ana.10519
20. Sherwin C., Fern R., Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF- α IL-1 β and calcium. Journal of Immunology 2005 175 1 155 161 2-s2.0-21244482466
21. Abo-Ouf H., Hooper A. W., White E. J., van Rensburg H. J. J., Trigatti B. L., Igdoura S. A., Deletion of tumor necrosis factor- α ameliorates neurodegeneration in Sandhoff disease mice. Human Molecular Genetics 2013 1 16 10.1093/hmg/ddt250
22. Lu M. O., Duan R. S., Quezada H. C., Chen Z.-G., Mix E., Jin T., Yang X., Ljunggren H.-G., Zhu J., Aggravation of experimental autoimmune neuritis in TNF- α receptor 1 deficient mice. Journal of Neuroimmunology 2007 186 1-2 19 26 2-s2.0-34248671665 10.1016/j.jneuroim.2007.02.004
23. Chertoff M., Di Paolo N., Schoeneberg A., Depino A., Ferrari C., Wurst W., Pfizenmaier K., Eisel U., Pitossi F., Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice. Experimental Neurology 2011 227 2 237 251 2-s2.0-78651445612 10.1016/j.expneurol.2010.11.010
24. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.-H., Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Research Reviews 2005 48 1 16 42 2-s2.0-13444278829 10.1016/j.brainresrev.2004.07.021
25. Yang G., Meng Y., Li W., Yong Y., Fan Z., Ding H., Wei Y., Luo J., Ke Z.-J., Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathology 2011 21 3 279 297 2-s2.0-79954615141 10.1111/j.1750-3639.2010.00445.x
26. Eugenin E. A., D'Aversa T. G., Lopez L., Calderon T. M., Berman J. W., MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. Journal of Neurochemistry 2003 85 5 1299 1311 2-s2.0-0038579653 10.1046/j.1471-4159.2003.01775.x
27. Thompson W. L., Karpus W. J., Van Eldik L. J., MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. Journal of Neuroinflammation 2008 5, article 35 2-s2.0-51249095407 10.1186/1742-2094-5-35
28. +-induced neurodegeneration. NeuroMolecular Medicine 2012 4 317 327
29. Salmaggi A., Ciusani E., De Rossi M., Gelati M., Dufour A., Corsini E., Pagano S., Baccalini R., Ferrero E., Silei V., Expression and modulation of IFN- γ -inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. Journal of Interferon and Cytokine Research 2002 22 6 631 640 2-s2.0-18544367984 10.1089/10799900260100114
30. Cinque P., Bestetti A., Marenzi R., Sala S., Gisslen M., Hagberg L., Price R. W., Cerebrospinal fluid interferon- γ -inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. Journal of Neuroimmunology 2005 168 1-2 154 163 2-s2.0-25844519831 10.1016/j.jneuroim.2005.07.002
31. Xia M. Q., Bacskai B. J., Knowles R. B., Qin S. X., Hyman B. T., Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. Journal of Neuroimmunology 2000 108 1-2 227 235 2-s2.0-0034256053 10.1016/S0165-5728(00)00285-X
32. Sui Y., Stehno-Bittel L., Li S., Loganathan R., Dhillon N. K., Pinson D., Nath A., Kolson D., Narayan O., Buch S., CXCL10-induced cell death in neurons: role of calcium dysregulation. European Journal of Neuroscience 2006 23 4 957 964 2-s2.0-33644781577 10.1111/j.1460-9568.2006.04631.x
33. Mattison H. A., Nie H., Gao H., Zhou H., Zhang J. S., Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice. Journal of Neuroimmunology 2013 257 1-2 110 115
34. Semple B. D., Bye N., Ziebell J. M., Morganti-Kossmann M. C., Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiology of Disease 2010 40 2 394 403 2-s2.0-79953091772 10.1016/j.nbd.2010.06.015
35. De Paola M., Buanne P., Biordi L., Bertini R., Ghezzi P., Mennini T., Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures. NeuroImmunoModulation 2007 14 6 310 316 2-s2.0-44349130492 10.1159/000123834
36. Roy M., Richard J.-F., Dumas A., Vallières L., CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis. Journal of Neuroinflammation 2012 9, article 18 2-s2.0-84856053756 10.1186/1742-2094-9-18
37. Zhu Y., Murakami F., Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives. Developmental Neurobiology 2012 72 10 1349 1362
38. Li M., Ransohoff R. M., Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Progress in Neurobiology 2008 84 2 116 131 2-s2.0-38749136238 10.1016/j.pneurobio.2007.11. 003
39. Shimoji M., Pagan F., Healton E. B., Mocchetti I., CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease. Neurotoxicity Research 2009 16 3 318 328 2-s2.0-70349909667 10.1007/s12640-009- 9076-3
40. Savarin-Vuaillat C., Ransohoff R. M., Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 2007 4 4 590 601 2-s2.0-34848825439 10.1016/j.nurt.2007.07.004
41. Owens T., Babcock A. A., Millward J. M., Toft-Hansen H., Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Research Reviews 2005 48 2 178 184 2-s2.0-17844392320 10.1016/j.brainresrev.2004.12.007
42. Eskandari F., Webster J. I., Sternberg E. M., Neural immune pathways and their connection to inflammatory diseases. Arthritis Research and Therapy 2003 5 6 251 265 2-s2.0-0242708722
43. Smith J. A., Das A., Ray S. K., Banik N. L., Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Research Bulletin 2012 87 1 10 20 2-s2.0-84155162481 10.1016/j.brainresbull.2011.10.004
44. Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H., Mechanisms underlying inflammation in neurodegeneration. Cell 2010 140 6 918 934 2-s2.0-77950363010 10.1016/j.cell.2010.02.016
45. Fallon B. A., Levin E. S., Schweitzer P. J., Hardesty D., Inflammation and central nervous system Lyme disease. Neurobiology of Disease 2010 37 3 534 541 2-s2.0-75949127593 10.1016/j.nbd.2009.11.016
46. Asbury A. K., Arnason B. G., Adams R. D., The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine 1969 48 3 173 215 2-s2.0-0014518216
47. Halperin J. J., Lyme disease and the peripheral nervous system. Muscle and Nerve 2003 28 2 133 143 2-s2.0-0041766765 10.1002/mus.10337
48. Bogliun G., Beghi E., Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurologica Scandinavica 2004 110 2 100 106 2-s2.0-3843123268 10.1111/j.1600-0404.2004. 00272.x
49. Kiguchi N., Kobayashi Y., Kishioka S., Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Current Opinion in Pharmacology 2012 12 1 55 61 2-s2.0-84857236125 10.1016/j.coph.2011.10.007
50. Scheld W. M., Koedel U., Nathan B., Pfister H.-W., Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. Journal of Infectious Diseases 2002 186 2 S225 S233 2-s2.0-0036890739 10.1086/344939
51. Nau R., Brück W., Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends in Neurosciences 2002 25 1 38 45 2-s2.0-0036155726 10.1016/S0166-2236(00)02024-5
52. Zysk G., Brück W., Huitinga I., Fischer F. R., Flachsbarth F., Van Rooijen N., Nau R., Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. Journal of Neuroimmunology 1997 73 1-2 77 80 2-s2.0-0343811704 10.1016/S0165-5728(96)00173-7
53. Täuber M. G., Moser B., Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clinical Infectious Diseases 1999 28 1 1 12 2-s2.0-0032987950
54. Trostdorf F., Brück W., Schmitz-Salue M., Stuertz K., Hopkins S. J., Van Rooijen N., Huitinga I., Nau R., Reduction of meningeal macrophages does not decrease migration of granulocytes into the CSF and brain parenchyma in experimental pneumococcal meningitis. Journal of Neuroimmunology 1999 99 2 205 210 2-s2.0-0345035378 10.1016/S0165-5728(99)00121-6
55. Pfister H.-W., Scheld W. M., Brain injury in bacterial meningitis: therapeutic implications. Current Opinion in Neurology 1997 10 3 254 259 2-s2.0-0030857648
56. Koedel U., Scheld W. M., Pfister H.-W., Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infectious Diseases 2002 2 12 721 736 2-s2.0-0036900042 10.1016/S1473-3099(02)00450-4
57. Nau R., Brück W., Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends in Neurosciences 2002 25 1 38 45 2-s2.0-0036155726 10.1016/S0166-2236(00)02024-5
58. Hanisch U. K., Prinz M., Angstwurm K., The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. European Journal of Immunology 2001 31 7 2104 2115
59. Rock R. B., Gekker G., Hu S., Sheng W. S., Cheeran M., Lokensgard J. R., Peterson P. K., Role of microglia in central nervous system infections. Clinical Microbiology Reviews 2004 17 4 942 964 2-s2.0-5644271409 10.1128/CMR.17.4.942- 964.2004
60. Braun J. S., Novak R., Murray P. J., Eischen C. M., Susin S. A., Kroemer G., Halle A., Weber J. R., Tuomanen E. I., Cleveland J. L., Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. Journal of Infectious Diseases 2001 184 10 1300 1309 2-s2.0-0035890012 10.1086/324013
61. Gerber J., Nau R., Mechanisms of injury in bacterial meningitis. Current Opinion in Neurology 2010 23 3 312 318 2-s2.0-77951950320 10.1097/WCO. 0b013e32833950dd
62. Fassbender K., Schminke U., Ries S., Ragoschke A., Kischka U., Fatar M., Hennerici M., Endothelial-derived adhesion molecules in bacterial meningitis: association to cytokine release and intrathecal leukocyte-recruitment. Journal of Neuroimmunology 1997 74 1-2 130 144 2-s2.0-0030936276 10.1016/S0165-5728(96) 00214-7
63. Täuber M. G., Moser B., Cytokines and chemokines in meningeal inflammation: biology and clinical implications. The Journal of Infectious Diseases 1985 151 3 528 534
64. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E., The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. Journal of Experimental Medicine 1990 171 2 439 448 2-s2.0-0025138735
65. Gerber J., Raivich G., Wellmer A., Noeske C., Kunst T., Werner A., Brück W., Nau R., A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathologica 2001 101 5 499 508 2-s2.0-0034958369
66. Grandgirard D., Steiner O., Täuber M. G., Leib S. L., An infant mouse model of brain damage in pneumococcal meningitis. Acta Neuropathologica 2007 114 6 609 617 2-s2.0-36349004263 10.1007/s00401-007-0304-8
67. Saladino R. A., Stack A. M., Fleisher G. R., Thompson C. M., Briles D. E., Kobzik L., Siber G. R., Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats. Infection and Immunity 1997 65 11 4701 4704 2-s2.0-0030786745
68. Grandgirard D., Burri M., Agyeman P., Leib S. L., Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother 2012 56 8 4289 4295
69. Gerber J., Böttcher T., Hahn M., Siemer A., Bunkowski S., Nau R., Increased mortality and spatial memory deficits in TNF- α -deficient mice in ceftriaxone-treated experimental pneumococcal meningitis. Neurobiology of Disease 2004 16 1 133 138 2-s2.0-2342477273 10.1016/j.nbd.2004.01.013
70. Sharief M. K., Ciardi M., Thompson E. J., Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor- α but not interleukin-1 β Journal of Infectious Diseases 1992 166 2 350 358 2-s2.0-0026696808
71. Zwijnenburg P. J. G., Van der Poll T., Florquin S., Roord J. J., Van Furth A. M., Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis. Infection and Immunity 2003 71 4 2276 2279 2-s2.0-0344837298 10.1128/IAI.71.4.2276-2279.2003
72. Zwijnenburg P. J. G., Van der Poll T., Florquin S., Roord J. J., Van Furth A. M., Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis. Infection and Immunity 2003 71 4 2276 2279 2-s2.0-0344837298 10.1128/IAI.71.4.2276-2279.2003
73. Orihuela C. J., Fillon S., Smith-Sielicki S. H., El Kasmi K. C., Gao G., Soulis K., Patil A., Murray P. J., Tuomanen E. I., Cell wall-mediated neuronal damage in early sepsis. Infection and Immunity 2006 74 7 3783 3789 2-s2.0-33745584400 10.1128/IAI.00022-06
74. Koedel U., Bernatowicz A., Frei K., Fontana A., Pfister H.-W., Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. Journal of Immunology 1996 157 11 5185 5191 2-s2.0-0030442779
75. Malipiero U., Koedel U., Pfister W., Fontana A., Bacterial meningitis: the role of transforming growth factor-beta in innate immunity and secondary brain damage. Neurodegenerative Diseases 2007 4 1 43 50 2-s2.0-34247120545 10.1159/000100358
76. Ebert S., Phillips D. J., Jenzewski P., Nau R., O'Connor A. E., Michel U., Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis. Journal of the Neurological Sciences 2006 250 1-2 50 57 2-s2.0-33750512122 10.1016/j.jns.2006.06.026
77. Wilms H., Schwark T., Brandenburg L.-O., Sievers J., Dengler R., Deuschl G., Lucius R., Regulation of activin A synthesis in microglial cells: pathophysiological implications for bacterial meningitis. Journal of Neuroscience Research 2010 88 1 16 23 2-s2.0-73949148927 10.1002/jnr.22185
78. Kastenbauer S., Angele B., Sporer B., Pfister H.-W., Koedel U., Patterns of protein expression in infectious meningitis: a cerebrospinal fluid protein array analysis. Journal of Neuroimmunology 2005 164 1-2 134 139 2-s2.0-20444484392 10.1016/j.jneuroim.2005.03.009
79. Spanaus K.-S., Nadal D., Pfister H.-W., Seebach J., Widmer U., Frei K., Gloor S., Fontana A., C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. Journal of Immunology 1997 158 4 1956 1964 2-s2.0-0031568386
80. Zwijnenburg P. J. G., De Bie H. M. A., Roord J. J., Van Der Poll T., Van Furth A. M., Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. Journal of Neuroimmunology 2003 145 1-2 148 153 2-s2.0-0345303857 10.1016/j.jneuroim.2003.09.013
81. Holub M., Beran O., Dzupová O., Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Critical Care 2007 11 2 R41
82. Klein M., Paul R., Angele B., Popp B., Pfister H.-W., Koedel U., Protein expression pattern in experimental pneumococcal meningitis. Microbes and Infection 2006 8 4 974 983 2-s2.0-33646163443 10.1016/j.micinf.2005.10.013
83. Stergaard C., Yieng-Kow R. V., Larsen C. G., Mukaida N., Matsushima K., Benfield T., Frimodt-Møller N., Espersen F., Kharazmi A., Lundgren J. D., Treatment with a monoclonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clinical and Experimental Immunology 2000 122 2 207 211 2-s2.0-0033623579 10.1046/j.1365-2249.2000.01357.x
84. Prinz M., Kann O., Draheim H. J., Schumann R. R., Kettenmann H., Weber J. R., Hanisch U.-K., Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines. Journal of Neuropathology and Experimental Neurology 1999 58 10 1078 1089 2-s2.0-0032866588
85. Banerjee A., van Sorge N. M., Sheen T. R., Uchiyama S., Mitchell T. J., Doran K. S., Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cellular Microbiology 2010 12 11 1576 1588 2-s2.0-78651414195 10.1111/j.1462-5822.2010.01490.x
86. Mook-Kanamori B. B., Geldhoff M., van der Poll T., van de Beek D., Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical Microbiology Reviews 2011 24 3 557 591 2-s2.0-79960123424 10.1128/CMR.00008-11
87. Mathisen G. E., Johnson J. P., Brain abscess. Clinical Infectious Diseases 1997 4 763 779
88. Prasad K. N., Mishra A. M., Gupta D., Husain N., Husain M., Gupta R. K., Analysis of microbial etiology and mortality in patients with brain abscess. Journal of Infection 2006 53 4 221 227 2-s2.0-33748559871 10.1016/j.jinf.2005. 12.002
89. Townsend G. C., Scheld W. M., Infections of the central nervous system. Advances in Internal Medicine 1998 43 403 447 2-s2.0-0031608167
90. Kielian T., Bearden E. D., Baldwin A. C., Esen N., IL-1 and TNF- α play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus -induced experimental brain abscess. Journal of Neuropathology and Experimental Neurology 2004 63 4 381 396 2-s2.0-1842458394
91. Baldwin A. C., Kielian T., Persistent immune activation associated with a mouse model of Staphylococcus aureus -induced experimental brain abscess. Journal of Neuroimmunology 2004 151 1-2 24 32 2-s2.0-2442566717 10.1016/j.jneuroim.2004.02.002
92. Kielian T., Barry B., Hickey W. F., CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. Journal of Immunology 2001 166 7 4634 4643 2-s2.0-0035313548
93. Kielian T., Phulwani N. K., Esen N., Syed M. M., Haney A. C., McCastlain K., Johnson J., MyD88-dependent signals are essential for the host immune response in experimental brain abscess. Journal of Immunology 2007 178 7 4528 4537 2-s2.0-33947685006
94. Kielian T., Mayes P., Kielian M., Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. Journal of Neuroimmunology 2002 130 1-2 86 99 2-s2.0-0036709090 10.1016/S0165-5728(02)00216-3
95. Kielian T., Esen N., Bearden E. D., Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. GLIA 2005 49 4 567 576 2-s2.0-14844348476 10.1002/glia.20144
96. Gurley C., Nichols J., Liu S., Phulwani N. K., Esen N., Kielian T., Microglia and astrocyte activation by Toll-like receptor ligands: modulation by PPAR- γ agonists. PPAR Research 2008 2008 15 2-s2.0-47349083019 10.1155/2008/453120 453120
97. Esen N., Kielian T., Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. Journal of Immunology 2006 176 11 6802 6811 2-s2.0-33646860198
98. Rath T. J., Hughes M., Arabi M., Shah G. V., Imaging of cerebritis, encephalitis, and brain abscess. Neuroimaging Clinics of North America 2012 4 585 607
99. Flaris N. A., Hickey W. F., Development and characterization of an experimental model of brain abscess in the rat. American Journal of Pathology 1992 141 6 1299 1307 2-s2.0-0027099666
100. Kielian T., Hickey W. F., Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. American Journal of Pathology 2000 157 2 647 658 2-s2.0-0033870421
101. Esen N., Wagoner G., Philips N., Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model. Journal of Neuroimmunology 2010 218 1-2 83 93 2-s2.0-73149095799 10.1016/j.jneuroim.2009. 10.006
102. Kielian T., Immunopathogenesis of brain abscess. Journal of Neuroinflammation 2004 1 1, article 16 2-s2.0-18144397888 10.1186/1742-2094-1-16
103. Cassateua M. A., Neutrophil-derived proteins: selling cytokines by the pound. Advances in Immunology 1999 73 369 509 2-s2.0-0033067441
104. Lo W. D., Chen R., Boue D. R., Stokes B. T., Effect of neutrophil depletion in acute cerebritis. Brain Research 1998 802 1-2 175 183 2-s2.0-0345404484 10.1016/S0006-8993(98)00600-3
105. Kielian T., Esen N., Liu S., Phulwani N. K., Syed M. M., Phillips N., Nishina K., Cheung A. L., Schwartzman J. D., Ruhe J. J., Minocycline modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus -induced brain abscess. American Journal of Pathology 2007 171 4 1199 1214 2-s2.0-35348910084 10.2353/ajpath.2007.070231
106. Burgdorfer W., Barbour A. G., Hayes S. F., Lyme disease-a tick-borne spirochetosis? Science 1982 216 4552 1317 1319 2-s2.0-0020312495
107. Rupprecht T. A., Koedel U., Fingerle V., Pfister H.-W., The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Molecular Medicine 2008 14 3-4 205 212 2-s2.0-41649118420 10.2119/2007-00091.Rupprecht
108. Halperin J. J., Nervous system Lyme disease. Journal of the Royal College of Physicians of Edinburgh 2010 40 3 248 255 2-s2.0-77957362623 10.4997/JRCPE.2010.314
109. Fallon B. A., Levin E. S., Schweitzer P. J., Hardesty D., Inflammation and central nervous system Lyme disease. Neurobiology of Disease 2010 37 3 534 541 2-s2.0-75949127593 10.1016/j.nbd.2009.11.016
110. Elamin M., Monaghan T., Mulllins G., Ali E., Corbett-Feeney G., O'Connell S., Counihan T. J., The clinical spectrum of Lyme neuroborreliosis. Irish Medical Journal 2010 103 2 46 49 2-s2.0-77949742740
111. Lana-Peixoto M. A., Multiple sclerosis and positive Lyme serology. Arquivos de Neuro-Psiquiatria 1994 52 4 566 571 2-s2.0-0028716376
112. Brinar V. V., Habek M., Rare infections mimicking MS. Clinical Neurology and Neurosurgery 2010 112 7 625 628 2-s2.0-77955654128 10.1016/j.clineuro.2010. 04.011
113. Oksi J., Kalimo H., Marttila R. J., Marjamäki M., Sonninen P., Nikoskelainen J., Viljanen M. K., Inflammatory brain changes in Lyme borreliosis A report on three patients and review of literature. Brain 1996 119 6 2143 2154 2-s2.0-0030476871
114. Keil R., Baron R., Kaiser R., Deuschl G., Vasculitic course of neuroborreliosis with thalamic infarction. Nervenarzt 1997 68 4 339 341 2-s2.0-0031010641 10.1007/s001150050133
115. Topakian R., Stieglbauer K., Nussbaumer K., Aichner F. T., Cerebral vasculitis and stroke in Lyme neuroborreliosis: two case reports and review of current knowledge. Cerebrovascular Diseases 2008 26 5 455 461 2-s2.0-52049095513 10.1159/000155982
116. Kohler J., Lyme borreliosis: a case of transverse myelitis with syrinx cavity. Neurology 1989 39 11 1553 1554 2-s2.0-0024853694
117. Benach J. L., Cameron D. J., Donnenberg M. S., Luft B. J., Dattwyler R. J., Borrelia burgdorferi in the central nervous system. Journal of the American Medical Association 1992 268 7 872 873 2-s2.0-1642463543 10.1001/jama.268.7.872
118. Duray P. H., Steere A. C., Clinical pathologic correlations of Lyme disease by stage. Annals of the New York Academy of Sciences 1988 539 65 79 2-s2.0-0023685753
119. Blanc F., Ballonzoli L., Marcel C., De Martino S., Jaulhac B., de Seze J., Lyme optic neuritis. Journal of the Neurological Sciences 2010 295 1-2 117 119 2-s2.0-77953871512 10.1016/j.jns.2010.05.009
120. Durovska J., Bazovska S., Pancak J., Zaborska M., Derdakova M., Traubner P., Infection with B. burgdorferi s.l., and the CNS demyelinating disease. A case report. Neuroendocrinology Letters 2011 32 4 411 414
121. Bigi S., Aebi C., Nauer C., Bigler S., Steinlin M., Acute transverse myelitis in Lyme neuroborreliosis. Infection 2010 38 5 413 416 2-s2.0-77957662122 10.1007/s15010-010-0028-x
122. Vallat J. M., Hugon J., Lubeau M., Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 1987 37 5 749 753 2-s2.0-0023268561
123. Logigian E. L., Peripheral nervous system Lyme borreliosis. Seminars in Neurology 1997 17 1 25 28 2-s2.0-0030998469
124. Meurs L., Labeye D., Declercq I., Piéret F., Gille M., Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. European Neurology 2004 52 3 186 188 2-s2.0-9244230652 10.1159/000081864
125. Koc F., Bozdemir H., Pekoz T., Aksu H. S., Ozcan S., Kurdak H., Lyme disease presenting as subacute transverse myelitis. Acta Neurologica Belgica 2009 109 4 326 329 2-s2.0-75149140147
126. Halperin J., Luft B. J., Volkman D. J., Dattwyler R. J., Lyme neuroborreliosis: peripheral nervous system manifestations. Brain 1990 113 4 1207 1221 2-s2.0-0025170526
127. Halperin J. J., Neuroborreliosis. American Journal of Medicine 1995 98 4 52S 56S
128. Sellati T. J., Burns M. J., Ficazzola M. A., Furie M. B., Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infection and Immunity 1995 63 11 4439 4447 2-s2.0-0028829239
129. Garcia-Monco J. C., Fernandez Villar B., Benach J. L., Lyme borreliosis: neurological features. Neurologia 1990 5 9 315 322 2-s2.0-0025646747
130. Meurers B., Kohlhepp W., Gold R., Rohrbach E., Mertens H. G., Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases. Journal of Neurology 1990 237 2 113 116 2-s2.0-0025274065 10.1007/BF00314674
131. Duray P. H., Histopathology of clinical phases of human Lyme disease. Rheumatic Disease Clinics of North America 1989 15 4 691 710 2-s2.0-0024369464
132. Weller M., Stevens A., Sommer N., Wietholter H., Dichgans J., Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Archives of Neurology 1991 48 8 837 841 2-s2.0-0026323245
133. Grusell M., Widhe M., Ekerfelt C., Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. Journal of Neuroimmunology 2002 131 1-2 173 178 2-s2.0-0036789981 10.1016/S0165-5728(02) 00255-2
134. Widhe M., Jarefors S., Ekerfelt C., Vrethem M., Bergström S., Forsberg P., Ernerudh J., Borrelia-specific interferon- γ and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. Journal of Infectious Diseases 2004 189 10 1881 1891 2-s2.0-2442707597 10.1086/382893
135. Widhe M., Skogman B. H., Jarefors S., Eknefelt M., Eneström G., Nordwall M., Ekerfelt C., Croner S., Bergström S., Forsberg P., Ernerudh J., Up-regulation of Borrelia-specific IL-4- and IFN- γ -secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. International Immunology 2005 17 10 1283 1291 2-s2.0-27144441405 10.1093/intimm/dxh304
136. Grygorczuk S., Zajkowska J., Swierzbińska R., Pancewicz S., Kondrusik M., Hermanowska-Szpakowicz T., Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis. Roczniki Akademii Medycznej w Białymstoku 2005 50 173 178 2-s2.0-33644816957
137. Rupprecht T. A., Koedel U., Muhlberger B., Wilske B., Fontana A., Pfister H.-W., CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis. Journal of Neurology 2005 252 7 820 823 2-s2.0-22144480900 10.1007/s00415-005-0752-9
138. Rupprecht T. A., Pfister H.-W., Angele B., Kastenbauer S., Wilske B., Koedel U., The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005 65 3 448 450 2-s2.0-23244451577 10.1212/01.wnl.0000171349.06645.79
139. Ljøstad U., Mygland Å., CSF B-Lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Journal of Neurology 2008 255 5 732 737 2-s2.0-44449150954 10.1007/s00415-008-0785-y
140. Kowarik M. C., Cepok S., Sellner J., CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. Journal of
141. Rupprecht T., Koedel U., Angele B., Fingerle V., Pfister H.-W., Cytokine CXCL13-a possible early CSF marker for neuroborreliosis. Nervenarzt 2006 77 4 470 473 2-s2.0-33645460038 10.1007/s00115-005-2021-7
142. Cadavid D., The mammalian host response to borrelia infection. Wiener Klinische Wochenschrift 2006 118 21-22 653 658 2-s2.0-33845672054 10.1007/s00508-006-0692-0
143. Halperin J. J., Heyes M. P., Neuroactive kynurenines in Lyme borreliosis. Neurology 1992 42 1 43 50 2-s2.0-0026542519
144. Petit T. L., The neurobiology of learning and memory: elucidation of the mechanisms of cognitive dysfunction. NeuroToxicology 1988 9 3 413 428 2-s2.0-0023709192
145. Chaparro-Huerta V., Rivera-Cervantes M. C., Flores-Soto M. E., Gómez-Pinedo U., Beas-Zárate C., Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. Journal of Neuroimmunology 2005 165 1-2 53 62 2-s2.0-22144488038 10.1016/j.jneuroim.2005.04.025
146. Philipp M. T., Aydintug M. K., Bohm R. P. Jr., Cogswell F. B., Dennis V. A., Lanners H. N., Lowrie R. C. Jr., Roberts E. D., Conway M. D., Karacorlu M., Peyman G. A., Gubler D. J., Johnson B. J. B., Piesman J., Gu Y., Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infection and Immunity 1993 61 7 3047 3059 2-s2.0-0027200214
147. Pachner A. R., Delaney E., O'Neill T., Major E., Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995 45 1 165 172 2-s2.0-0028795671
148. Norgard M. V., Arndt L. L., Akins D. R., Curetty L. L., Harrich D. A., Radolf J. D., Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF- B. Infection and Immunity 1996 64 9 3845 3852 2-s2.0-0029782133
149. Ramesh G., Alvarez A. L., Roberts E. D., Dennis V. A., Lasater B. L., Alvarez X., Philipp M. T., Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. European Journal of Immunology 2003 33 9 2539 2550 2-s2.0-0141650488 10.1002/eji.200323872
150. Ramesh G., Philipp M. T., Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neuroscience Letters 2005 384 1-2 112 116 2-s2.0-20444465958 10.1016/j.neulet.2005.04.069
151. Bernardino A. L. F., Myers T. A., Alvarez X., Hasegawa A., Philipp M. T., Toll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosis. Infection and Immunity 2008 76 10 4385 4395 2-s2.0-53649111609 10.1128/IAI.00394-08
152. Myers T. A., Kaushal D., Philipp M. T., Microglia are mediators of Borrelia burgdorferi -induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathogens 2009 5 11 2-s2.0-73549087878 10.1371/journal.ppat.1000659 e1000659
153. Ramesh G., Borda J. T., Dufour J., Kaushal D., Ramamoorthy R., Lackner A. A., Philipp M. T., Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. American Journal of Pathology 2008 173 5 1415 1427 2-s2.0-55349148039 10.2353/ajpath.2008.080483
154. Ramesh G., Borda J. T., Gill A., Ribka E. P., Morici L. A., Mottram P., Martin D. S., Jacobs M. B., Didier P. J., Philipp M. T., Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. Journal of Neuroinflammation 2009 6, article 23 2-s2.0-71049143886 10.1186/1742-2094-6-23
155. Pachner A. R., Amemiya K., Delaney E., O'Neill T., Hughes C. A. N., Zhang W.-F., Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997 49 1 147 152 2-s2.0-0030877314
156. Narayan K., Dail D., Li L., Cadavid D., Amrute S., Fitzgerald-Bocarsly P., Pachner A. R., The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Annals of Neurology 2005 57 6 813 823 2-s2.0-20444384342 10.1002/ana.20486
157. Pachner A. R., Steiner I., Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurology 2007 6 6 544 552 2-s2.0-34248371612 10.1016/S1474-4422(07)70128-X
158. Wei X. H., Na X. D., Liao G. J., The up-regulation of IL-6 in DRG and spinal horn contributes to neuopathic pain following L5 ventral horn transection. Experimental Neurology 2013 241 159 168
159. Ramesh G., Benge S., Pahar B., Philipp M. T., A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. Journal of Neuroinflammation 2012 2012 72 2-s2.0-84859935020 10.1186/1742-2094-9-72
160. Grütter M. G., Caspases: key players in programmed cell death. Current Opinion in Structural Biology 2000 10 6 649 655
161. Bø L., Vedeler C. A., Nyland H. I., Trapp B. D., Mørk S. J., Subpial demyelination in the cerebral cortex of multiple sclerosis patients. Journal of Neuropathology and Experimental Neurology 2003 62 7 723 732 2-s2.0-0037828315
162. Bradl M., Lassmann H., Oligodendrocytes: biology and pathology. Acta Neuropathologica 2010 119 1 37 53 2-s2.0-77649192930 10.1007/s00401-009-0601-5
163. Hisahara S., Okano H., Miura M., Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neuroscience Research 2003 46 4 387 397 2-s2.0-0037491616 10.1016/S0168-0102(03)00127-5
164. Stadelmann C., Wegner C., Brück W., Inflammation, demyelination, and degeneration-recent insights from MS pathology. Biochimica et Biophysica Acta 2011 1812 2 275 282 2-s2.0-78650172976 10.1016/j.bbadis.2010.07.007
165. Conductier G., Blondeau N., Guyon A., Nahon J.-L., Rovère C., The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. Journal of Neuroimmunology 2010 224 1-2 93 100 2-s2.0-77955090022 10.1016/j.jneuroim.2010.05.010
166. Gerard C., Rollins B. J., Chemokines and disease. Nature Immunology 2001 2 2 108 115 2-s2.0-0035260881 10.1038/84209
167. Rollins B. J., Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Molecular Medicine Today 1996 2 5 198 204 2-s2.0-0030140458 10.1016/1357-4310(96)88772-7
168. Simpson J. E., Newcombe J., Cuzner M. L., Woodroofe M. N., Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. Journal of Neuroimmunology 1998 84 2 238 249 2-s2.0-0032522207 10.1016/S0165-5728(97)00208-7
169. Ransohoff R. M., Hamilton T. A., Tani M., Stoler M. H., Shick H. E., Major J. A., Estes M. L., Thomas D. M., Tuohy V. K., Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB Journal 1993 7 6 592 600 2-s2.0-0027530096
170. Hinojosa A. E., Garcia-Bueno B., Leza J. C., Madrigal J. L. M., CCL2/MCP-1 modulation of microglial activation and proliferation. Journal of Neuroinflammation 2011 8, article 77 2-s2.0-79959835836 10.1186/1742-2094-8-77
171. Perrin F. E., Lacroix S., Avilés-Trigueros M., David S., Involvement of moncyte chemo-attractant protein-1, macrophage inflammatory protein-1 alpha and interleukin-1 beta in Wallerian degeneration. Brain 2005 128, part 4 854 866
172. Kindstrand E., Nilsson B. Y., Hovmark A., Nennesmo I., Pirskanen R., Solders G., Åsbrink E., Polyneuropathy in late Lyme borreliosis-a clinical, neurophysiological and morphological description. Acta Neurologica Scandinavica 2000 101 1 47 52 2-s2.0-0033980670 10.1034/j.1600-0404.2000.00009.x
173. Merrill J. E., Benveniste E. N., Cytokines in inflammatory brain lesions: helpful and harmful. Trends in Neurosciences 1996 19 8 331 338 2-s2.0-0030221758 10.1016/0166-2236(96)10047-3
174. Rothwell N. J., Strijbos P. J. L. M., Cytokines in neurodegeneration and repair. International Journal of Developmental Neuroscience 1995 13 3-4 179 185 2-s2.0-0029035926 10.1016/0736-5748(95)00018-C
175. Raivich G., Jones L. L., Werner A., Blüthmann H., Doetschmann T., Kreutzberg G. W., Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochirurgica, Supplement 1999 1999 73 21 30 2-s2.0-0032611532
176. Minghetti L., Role of inflammation in neurodegenerative diseases. Current Opinion in Neurology 2005 18 3 315 321 2-s2.0-20444466786
177. Schmitz T., Chew L.-J., Cytokines and myelination in the central nervous system. The Scientific World Journal 2008 8 1119 1147 2-s2.0-56749175020 10.1100/tsw.2008.140
178. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S., Interleukin-6, a mental cytokine. Brain Research Reviews 2011 67 1-2 157 183 2-s2.0-79957949411 10.1016/j.brainresrev.2011.01.002
179. Pizzi M., Sarnico I., Boroni F., Benarese M., Dreano M., Garotta G., Valerio A., Spano P., Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Molecular and Cellular Neuroscience 2004 25 2 301 311 2-s2.0-1542407681 10.1016/j.mcn.2003.10.022
180. Barres B. A., Schmid R., Sendnter M., Raff M. C., Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993 118 1 283 295 2-s2.0-0027299467
181. Grygorczuk S., Pancewicz S., Zajkowska J., Kondrusik M., Świerzbińska R., Hermanowska-Szpakowicz T., Concentrations of macrophage inflammatory proteins MIP-1 α and MIP-1 β and interleukin 8 (Il-8) in Lyme borreliosis. Infection 2004 32 6 350 355 2-s2.0-12144263655 10.1007/s15010-004-3110-4
182. Kossmann T., Stahel P. F., Lenzlinger P. M., Redl H., Dubs R. W., Trentz O., Schlag G., Morganti-Kossmann M. C., Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. Journal of Cerebral Blood Flow and Metabolism 1997 17 3 280 289 2-s2.0-0030939399
183. Dumont R. A., Car B. D., Voitenok N. N., Junker U., Moser B., Zak O., O'Reilly T., Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infection and Immunity 2000 68 10 5756 5763 2-s2.0-0033796705 10.1128/IAI.68.10.5756-5763.2000
184. Thirumangalakudi L., Yin L., Rao H. V., Grammas P., IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. Journal of Alzheimer's Disease 2007 11 3 305 311 2-s2.0-34447648515
185. Nordberg M., Forsberg P., Johansson A., Nyman D., Jansson C., Ernerudh J., Ekerfelt C., Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis. Journal of Neuroimmunology 2011 232 1-2 186 193 2-s2.0-79952241552 10.1016/j.jneuroim.2010. 09.028
186. Ekerfelt C., Jarefors S., Tynngård N., Hedlund M., Sander B., Bergström S., Forsberg P., Ernerudh J., Phenotypes indicating cytolytic properties of Borrelia-specific interferon- γ secreting cells in chronic Lyme neuroborreliosis. Journal of Neuroimmunology 2003 145 1-2 115 126 2-s2.0-0345171686 10.1016/j.jneuroim.2003.08.037
187. Rasley A., Tranguch S. L., Rati D. M., Marriott I., Murine glia express the immunosuppressive cytokine, interleukin-10, following exposure to Borrelia burgdorferi or Neisseria meningitidis. GLIA 2006 53 6 583 592 2-s2.0-33646000807 10.1002/glia.20314
188. Bernardino A. L. F., Kaushal D., Philipp M. T., The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete borrelia burgdorferi. Journal of Infectious Diseases 2009 199 9 1379 1388 2-s2.0-65749115383 10.1086/597807
189. McArthur J. C., Brew B. J., Nath A., Neurological complications of HIV infection. Lancet Neurology 2005 4 9 543 555 2-s2.0-23744505999 10.1016/S1474-4422(05)70165-4
190. Brabers N. A. C. H., Nottet H. S. L. M., Role of the pro-inflammatory cytokines TNF- α and IL-1 β in HIV-associated dementia. European Journal of Clinical Investigation 2006 36 7 447 458 2-s2.0-33745011334 10.1111/j.1365-2362.2006.01657.x
191. Hallett M. B., Lloyds D., Neutrophil priming: the cellular signals that say "amber" but not "green" Immunology Today 1995 16 6 264 268 2-s2.0-0029008602 10.1016/0167-5699(95)80178-2
192. Elbim C., Pillet S., Prevost M. H., Preira A., Girard P. M., Rogine N., Matusani H., Hakim J., Israel N., Gougerot-Pocidalo M. A., Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. Journal of Virology 1999 73 6 4561 4566 2-s2.0-0032992605
193. Renner N. A., Ivey N. S., Redmann R. K., Lackner A. A., MacLean A. G., MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis. Journal of NeuroVirology 2011 17 2 146 152 2-s2.0-79960027354 10.1007/s13365-010-0017-y
194. Thompson W. L., Van Eldik L. J., Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NF B and MAPK dependent pathways in rat astrocytes. Brain Research 2009 1287 47 57 2-s2.0-68049083543 10.1016/j.brainres.2009.06.081
195. Orandle M. S., MacLean A. G., Sasseville V. G., Alvarez X., Lackner A. A., Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. Journal of Virology 2002 76 11 5797 5802 2-s2.0-0036095147 10.1128/JVI.76.11.5797-5802.2002
196. Cardona A. E., Gonzalez P. A., Teale J. M., CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of γ δ T cells in amplification of the host immune response. Infection and Immunity 2003 71 5 2634 2642 2-s2.0-0037408329 10.1128/IAI.71.5.2634-2642.2003
197. Voskuhl R. R., Peterson R. S., Song B., Ao Y., Morales L. B. J., Tiwari-Woodruff S., Sofroniew M. V., Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. Journal of Neuroscience 2009 29 37 11511 11522 2-s2.0-70349103383 10.1523/JNEUROSCI.1514-09.2009
198. Kielian T., Immunopathogenesis of brain abscess. Journal of Neuroinflammation 2004 1 1, article 16 2-s2.0-18144397888 10.1186/1742-2094-1-16
199. Cota M., Kleinschmidt A., Ceccherini-Silberstein F., Aloisi F., Mengozzi M., Mantovani A., Brack-Werner R., Poli G., Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. Journal of NeuroVirology 2000 6 1 75 83 2-s2.0-0034068785
200. Eugenin E. A., Osiecki K., Lopez L., Goldstein H., Calderon T. M., Berman J. W., CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. Journal of Neuroscience 2006 26 4 1098 1106 2-s2.0-32544437823 10.1523/JNEUROSCI.3863-05.2006
201. Hauwel M., Furon E., Canova C., Griffiths M., Neal J., Gasque P., Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Research Reviews 2005 48 2 220 233 2-s2.0-17844382673 10.1016/j.brainresrev.2004.12.012
202. Park E. J., Park S. Y., Joe E.-H., Jou I., 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. Journal of Biological Chemistry 2003 278 17 14747 14752 2-s2.0-0038352039 10.1074/jbc.M210819200
203. Fischer-Smith T., Rappaport J., Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Reviews in Molecular Medicine 2005 7 27 1 26 2-s2.0-31044455755 10.1017/S1462399405010239
204. Sasseville V. G., Lane J. H., Walsh D., Ringler D. J., Lackner A. A., VCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIV. Journal of Medical Primatology 1995 24 3 123 131 2-s2.0-0029296231
205. Sasseville V. G., Newman W. A., Lackner A. A., Smith M. O., Lausen N. C. G., Beall D., Ringler D. J., Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. American Journal of Pathology 1992 141 5 1021 1030 2-s2.0-0026445579
206. Mathew J. S., Westmoreland S. V., Alvarez X., Simon M. A., Pauley D. R., MacKey J. J., Lackner A. A., Expression of peripherin in the brain of macaques (Macaca mulatta and Macaca fascicularis) occurs in astrocytes rather than neurones and is associated with encephalitis. Neuropathology and Applied Neurobiology 2001 27 6 434 443 2-s2.0-0035727926 10.1046/j.1365-2990.2001.00361. x
207. Sasseville V. G., Smith M. M., Mackay C. R., Pauley D. R., Mansfield K. G., Ringler D. J., Lackner A. A., Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. American Journal of Pathology 1996 149 5 1459 1467 2-s2.0-0029951709
208. McKimmie C. S., Graham G. J., Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochemical and Biophysical Research Communications 2010 394 4 1006 1011 2-s2.0-77950858350 10.1016/j.bbrc.2010.03. 111
209. Sopper S., Demuth M., Stahl-Hennig C., Hunsmann G., Plesker R., Coulibaly C., Czub S., Ceska M., Koutsilieri E., Riederer P., Brinkmann R., Katz M., Ter Meulen V., The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from Rhesus monkey. Virology 1996 220 2 320 329 2-s2.0-0029896376 10.1006/viro.1996.0320
210. Köhler C., Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell and Tissue Research 2007 330 2 291 302 2-s2.0-34848891262 10.1007/s00441-007-0474-7
211. Ohsawa K., Imai Y., Sasaki Y., Kohsaka S., Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. Journal of Neurochemistry 2004 88 4 844 856 2-s2.0-1042301226
212. Tassi M., Calvente R., Marín-Teva J. L., Cuadros M. A., Santos A. M., Carrasco M.-C., Sánchez-López A. M., Navascués J., Behavior of in vitro cultured ameboid microglial cells migrating on Müller cell end-feet in the quail embryo retina. GLIA 2006 54 5 376 393 2-s2.0-33748857416 10.1002/glia.20393
213. Renner N. A., Sansing H. A., Morici L. A., Inglis F. M., Lackner A. A., Maclean A. G., Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion. Journal For Neurovirology 2012 18 3 213 221
214. Shaw K. T. Y., Greig N. H., Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. NeuroReport 1999 10 4 53 56 2-s2.0-0033577196
215. Renner N. A., Sansing H. A., Inglis F. M., Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes. Journal of Cellular Physiology 2013 228 6 1284 1294
216. Nyagol J., De Falco G., Lazzi S., Luzzi A., Cerino G., Shaheen S., Palummo N., Bellan C., Spina D., Leoncini L., HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. Journal of Hematopathology 2008 1 1 3 10 2-s2.0-41949117049 10.1007/s12308-008-0002-z
217. Garces C. A., Kurenova E. V., Golubovskaya V. M., Cance W. G., Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Research 2006 66 3 1446 1454 2-s2.0-32944475609 10.1158/0008-5472.CAN-05-1661
218. Ivey N. S., Renner N. A., Moroney T., Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization. Journal for Neurovirology 2009 10 1 12
219. Roberts E. S., Burudi E. M. E., Flynn C., Madden L. J., Roinick K. L., Watry D. D., Zandonatti M. A., Taffe M. A., Fox H. S., Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. Journal of Neuroimmunology 2004 157 1-2 81 92 2-s2.0-9644283128 10.1016/j.jneuroim.2004.08.030
220. Williams K. C., Hickey W. F., Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annual Review of Neuroscience 2002 25 537 562 2-s2.0-0036308234 10.1146/annurev.neuro.25.112701. 142822
221. Shah A., Verma A. S., Patel K. H., Noel R., Rivera-Amill V., Silverstein P. S., Chaudhary S., Bhat H. K., Stamatatos L., Singh D. P., Buch S., Kumar A., HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS ONE 2011 6 6 2-s2.0-79959330425 10.1371/journal.pone.0021261 e21261
222. Sugama S., Takenouchi T., Cho B. P., Joh T. H., Hashimoto M., Kitani H., Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflammation and Allergy 2009 8 4 277 284 2-s2.0-70349518598 10.2174/187152809789352249
223. D'Aversa T. G., Eugenin E. A., Berman J. W., CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor- B (NF B) and activator protein-1 (AP-1). Journal of Neuroscience Research 2008 86 3 630 639 2-s2.0-38849152403 10.1002/jnr.21525
224. Shah A., Kumar A., HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF- B pathway and can be silenced by gp120-specific siRNA. Journal of Neuroinflammation 2010 7, article 96 2-s2.0-78650591264 10.1186/1742-2094-7-96
225. Xiong H., Boyle J., Winkelbauer M., Gorantla S., Zheng J., Ghorpade A., Persidsky Y., Carlson K. A., Gendelman H. E., Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. Journal of Neuroscience Research 2003 71 4 600 607 2-s2.0-0037441556 10.1002/jnr.10503
226. Penton-Rol G., Cota M., Polentarutti N., Luini W., Bernasconi S., Borsatti A., Sica A., LaRosa G. J., Sozzani S., Poli G., Mantovani A., Up-regulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed, to glucocorticoid hormones. Journal of Immunology 1999 163 6 3524 3529 2-s2.0-0033568297
227. Witwer K. W., Gama L., Li M., Bartizal C. M., Queen S. E., Varrone J. J., Brice A. K., Graham D. R., Tarwater P. M., Mankowski J. L., Zink M. C., Clements J. E., Coordinated regulation of SIV replication and immune responses in the CNS. PLoS ONE 2009 4 12 e8129 2-s2.0-77949510093
228. Eugenin E. A., D'Aversa T. G., Lopez L., Calderon T. M., Berman J. W., MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. Journal of Neurochemistry 2003 85 5 1299 1311 2-s2.0-0038579653 10.1046/j.1471-4159.2003.01775.x
229. Kolb S. A., Sporer B., Lahrtz F., Koedel U., Pfister H.-W., Fontana A., Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon- γ inducible protein 10. Journal of Neuroimmunology 1999 93 1-2 172 181 2-s2.0-0032892113 10.1016/S0165-5728(98) 00223-9
230. Mankowski J. L., Queen S. E., Clements J. E., Zink M. C., Cerebrospinal fluid markers that predict SIV CNS disease. Journal of Neuroimmunology 2004 157 1-2 66 70 2-s2.0-9644283129 10.1016/j.jneuroim.2004.08.031
231. Williams K. C., Hickey W. F., Traffic of hematogenous cells through the central nervous system. Current Topics in Microbiology and Immunology 1995 202 221 245 2-s2.0-0029100832
232. Scholz J., Woolf C. J., The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience 2007 10 11 1361 1368 2-s2.0-35548937457 10.1038/nn1992
233. Dubový P., Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Annals of Anatomy 2011 193 4 267 275 2-s2.0-79960205373 10.1016/j.aanat.2011.02.011
234. Seifert F., Maihöfner C., Functional and structural imaging of pain-induced neuroplasticity. Current Opinion in Anaesthesiology 2011 24 5 515 523 2-s2.0-80052677078 10.1097/ACO.0b013e32834a1079
235. Abbadie C., Chemokines, chemokine receptors and pain. Trends in Immunology 2005 26 10 529 534 2-s2.0-24744468023 10.1016/j.it.2005.08.001
236. Abbadie C., Lindia J. A., Cumiskey A. M., Peterson L. B., Mudgett J. S., Bayne E. K., DeMartino J. A., MacIntyre D. E., Forrest M. J., Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7947 7952 2-s2.0-0037934294 10.1073/pnas.1331358100
237. White F. A., Bhangoo S. K., Miller R. J., Chemokines: integrators of pain and inflammation. Nature Reviews Drug Discovery 2005 4 10 834 844 2-s2.0-27644510131 10.1038/nrd1852
238. White F. A., Feldman P., Miller R. J., Chemokine signaling and the management of neuropathic pain. Molecular Interventions 2009 9 4 188 195 2-s2.0-69749104787 10.1124/mi.9.4.7
239. Ren K., Dubner R., Interactions between the immune and nervous systems in pain. Nature Medicine 2010 16 11 1267 1276 2-s2.0-78149357276 10.1038/nm.2234
240. Holmes F. E., Arnott N., Vanderplank P., Kerr N. C. H., Longbrake E. E., Popovich P. G., Imai T., Combadière C., Murphy P. M., Wynick D., Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. Journal of Neurochemistry 2008 106 2 640 649 2-s2.0-51649107644 10.1111/j.1471-4159.2008.05419.x
241. Moalem G., Tracey D. J., Immune and inflammatory mechanisms in neuropathic pain. Brain Research Reviews 2006 51 2 240 264 2-s2.0-33745153343 10.1016/j.brainresrev.2005.11.004
242. Coull J. A. M., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M. W., De Koninck Y., BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005 438 7070 1017 1021 2-s2.0-30744439794 10.1038/nature04223
243. Miyoshi K., Obata K., Kondo T., Okamura H., Noguchi K., Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. Journal of Neuroscience 2008 28 48 12775 12787 2-s2.0-58149391974 10.1523/JNEUROSCI.3512-08.2008
244. Binshtok A. M., Wang H., Zimmermann K., Amaya F., Vardeh D., Shi L., Brenner G. J., Ji R.-R., Bean B. P., Woolf C. J., Samad T. A., Nociceptors are interleukin-1 β sensors. Journal of Neuroscience 2008 28 52 14062 14073 2-s2.0-58149387593 10.1523/JNEUROSCI.3795-08.2008
245. Skoff A. M., Zhao C., Adler J. E., Interleukin-1 α regulates substance P expression and release in adult sensory neurons. Experimental Neurology 2009 217 2 395 400 2-s2.0-67349204771 10.1016/j.expneurol.2009.03.022
246. Xu X.-J., Hao J.-X., Andell-Jonsson S., Poli V., Bartfai T., Wiesenfeld-Hallin Z., Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 1997 9 12 1028 1033 2-s2.0-0031441582 10.1006/cyto.1997.0243
247. Dominguez E., Mauborgne A., Mallet J., Desclaux M., Pohl M., SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. Journal of Neuroscience 2010 30 16 5754 5766 2-s2.0-77951533730 10.1523/JNEUROSCI.5007-09.2010
248. Myers R. R., Shubayev V. I., The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF- α axonal transport in neuropathic pain. Journal of the Peripheral Nervous System 2011 16 4 277 286 2-s2.0-83755184177 10.1111/j.1529-8027.2011.00362.x
249. Kim C. F., Moalem-Taylor G., Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. Journal of Pain 2011 12 3 370 383 2-s2.0-79952440651 10.1016/j.jpain.2010. 08.003
250. Nũnéz S., Lee J.-S., Zhang Y., Bai G., Ro J. Y., Role of peripheral -opioid receptors in inflammatory orofacial muscle pain. Neuroscience 2007 146 3 1346 1354 2-s2.0-34247849237 10.1016/j.neuroscience.2007.02.024
251. Lee Y. K., Choi D. Y., Jung Y. Y., Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli. Neuropharmacology 2013 67 57 65
252. Kiguchi N., Kobayashi Y., Kishioka S., Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Current Opinion in Pharmacology 2012 12 1 55 61 2-s2.0-84857236125 10.1016/j.coph.2011.10.007